Kala Bio Inc (KALA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KALA | AZN | AMGN | GILD | BMY |
| Company | Kala Bio Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.9499 | 156.30 | 412.98 | 138.36 | 63.60 |
| High | 0.9955 | 157.26 | 419.60 | 139.49 | 64.74 |
| Low | 0.9000 | 155.78 | 410.40 | 136.63 | 63.36 |
| Last | 0.9102 | 156.89 | 419.38 | 138.92 | 64.63 |
| Change | -0.0353 | +0.44 | +4.17 | +0.56 | +0.80 |
| Percent Change | -3.73% | +0.28% | +1.00% | +0.40% | +1.25% |
| Volume | 117,900 | 3,361,500 | 2,880,500 | 3,940,300 | 7,289,100 |
| 20-Day Average Volume | 88,095 | 4,082,155 | 2,756,800 | 6,728,720 | 12,101,905 |
| Previous | 0.9455 | 156.45 | 415.21 | 138.36 | 63.83 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.7590 | 164.02 | 395.11 | 133.11 | 63.69 |
| 20-Day Raw Stochastic | 78.96% | 16.08% | 96.15% | 95.20% | 58.19% |
| 20-Day Relative Strength | 36.33 | 37.49 | 69.64 | 59.56 | 59.40 |
| Weighted Alpha | -96.65 | -11.53 | +47.08 | +19.36 | +36.59 |
| Today's Opinion | 88% Sell | 100% Sell | 100% Buy | 40% Buy | 100% Buy |
| Yesterday's Opinion | 88% Sell | 100% Sell | 100% Buy | 40% Buy | 100% Buy |
| Last Month's Opinion | 100% Sell | 88% Sell | 72% Buy | 8% Sell | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +20.56% since 08/10/26 | -3.10% since 08/10/26 | +0.52% since 08/10/26 | +4.40% since 08/10/26 | -0.32% since 08/10/26 |
| Low | 0.7500 on 08/11/26 | 154.53 on 08/14/26 | 409.00 on 08/12/26 | 132.01 on 08/11/26 | 63.00 on 08/12/26 |
| High | 0.9955 on 08/17/26 | 162.26 on 08/11/26 | 421.79 on 08/11/26 | 139.49 on 08/17/26 | 65.02 on 08/13/26 |
| 1-Month | |||||
| %Chg | +17.32% since 07/17/26 | -7.11% since 07/17/26 | +14.49% since 07/17/26 | +3.46% since 07/17/26 | +6.40% since 07/17/26 |
| Low | 0.5900 on 07/24/26 | 153.41 on 08/03/26 | 359.21 on 07/23/26 | 127.61 on 07/23/26 | 59.80 on 07/21/26 |
| High | 0.9955 on 08/17/26 | 175.04 on 07/29/26 | 421.79 on 08/11/26 | 139.49 on 08/17/26 | 68.10 on 08/03/26 |
| 3-Month | |||||
| %Chg | -68.94% since 05/15/26 | -13.60% since 05/15/26 | +28.52% since 05/15/26 | +7.21% since 05/15/26 | +13.39% since 05/15/26 |
| Low | 0.5900 on 07/24/26 | 153.41 on 08/03/26 | 320.96 on 05/19/26 | 121.39 on 06/10/26 | 53.44 on 06/18/26 |
| High | 3.7099 on 06/22/26 | 196.41 on 07/02/26 | 421.79 on 08/11/26 | 140.61 on 07/17/26 | 68.10 on 08/03/26 |
| 6-Month | |||||
| %Chg | -95.43% since 02/17/26 | -25.11% since 02/17/26 | +12.33% since 02/17/26 | -10.53% since 02/17/26 | +7.09% since 02/17/26 |
| Low | 0.5900 on 07/24/26 | 153.41 on 08/03/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 53.44 on 06/18/26 |
| High | 25.5000 on 03/11/26 | 212.71 on 02/18/26 | 421.79 on 08/11/26 | 156.01 on 02/18/26 | 68.10 on 08/03/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 18,286 | 242,639,536 | 224,475,824 | 171,560,160 | 130,386,496 |
| Shares Outstanding, K | 19,340 | 1,550,908 | 540,632 | 1,239,955 | 2,042,715 |
| Annual Sales, $M | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income, $M | -26,980,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Qtr Sales, $M | 0 | 15,384,000,000 | 10,054,000,000 | 7,803,000,000 | 12,973,000,000 |
| Last Qtr Income, $M | -1,620,000 | 2,507,000,000 | 2,375,000,000 | -10,496,000,000 | 3,317,000,000 |
| 60-Month Beta | -2.26 | 0.26 | 0.41 | 0.32 | 0.22 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.14 on 05/15/26 | 2.63 on 07/27/26 | 6.29 on 08/04/26 | -6.75 on 08/04/26 | 2.04 on 07/30/26 |
| Latest Earnings Date | 08/14/26 | 11/05/26 | 11/03/26 | 10/29/26 | 10/29/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | 0.630 on 07/02/26 |
| Next Ex-Dividend Date | N/A | 02/20/26 | 08/21/26 | 09/15/26 | 07/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.19 | 18.68 | 0.00 | 9.93 |